The central amygdala (CeA) is a key structure at the limbic-motor interface regulating stress responses and emotional learning. Endocannabinoid (eCB) signaling is heavily implicated in the regulation of stress-response physiology and emotional learning processes; however, the role of eCBs in the modulation of synaptic efficacy in the CeA is not well understood. Here we describe the subcellular localization of CB 1 cannabinoid receptors and eCB synthetic machinery at glutamatergic synapses in the CeA and find that CeA neurons exhibit multiple mechanistically and temporally distinct modes of postsynaptic eCB mobilization. These data identify a prominent role for eCBs in the modulation of excitatory drive to CeA neurons and provide insight into the mechanisms by which eCB signaling and exogenous cannabinoids could regulate stress responses and emotional learning.
INTRODUCTION
The central amygdala (CeA) plays a key role in emotional learning processes (Ehrlich et al., 2009; Pape and Pare, 2010) . Perhaps most well-studied is the role the CeA plays in unconditioned and conditioned fear generation Li et al., 2013; Tye et al., 2011) , fear extinction, and conditioned inhibition (Amano et al., 2010) , as well as conditioned orienting responses to emotionally salient stimuli (El-Amamy and Holland, 2007; Groshek et al., 2005) . The CeA is a subcortical structure composed of GABAergic neurons and divided into lateral (CeAL) and medial (CeAM) subdivisions (Cassell et al., 1999) . The CeAL acts as the primary input nucleus of the CeA and receives strong glutamatergic drive from cortical (McDonald et al., 1999) , thalamic (Li and Kirouac, 2008) , intra-amygdala, and brainstem sources and projects GABAergic axon terminals to the CeAM (Sun et al., 1994) . The CeAM, in turn, projects to downstream regions involved in the expression of fear and arousal responses to salient stimuli (Davis, 1997) . Functional studies have recently shown that activation of CeAL projection neurons strongly inhibits CeAM output neurons and reduces behavioral fear and anxiety responses Li et al., 2013; Tye et al., 2011) . Thus, enhanced inhibitory control of CeAM neurons by elevated activity of CeAL projection cells may serve to constrain conditioned fear and anxiety (Amano et al., 2010; Ciocchi et al., 2010) . Taken together, these data suggest that understanding the synaptic mechanisms regulating excitatory drive to CeAL neurons could provide significant insight into the mechanisms regulating the expression of fear and anxiety.
Endocannabinoids are a class of bioactive lipids produced by neurons and glia (Kano et al., 2009 ). 2-arachidonoylglycerol (2-AG) is thought to be the primary eCB that mediates retrograde synaptic signaling at central synapses (Castillo et al., 2012) . 2-AG is postsynaptically synthesized by diacylglycerol lipase a (DAGLa) via calcium-and Gq-protein-coupled receptor (GqPCR)-dependent mechanisms (Hashimotodani et al., , 2007 Ohno-Shosaku et al., 2005 . In contrast to 2-AG, the mechanisms regulating synaptic anandamide (AEA) synthesis are not well understood but can involve GqPCR activation (Chá vez et al., 2010; Grueter et al., 2010; Huang and Woolley, 2012) . Once produced, 2-AG and AEA are primarily degraded by monoacylglycerol lipase and fatty acid amide hydrolase, respectively (Cravatt et al., 2001; Dinh et al., 2002; Long et al., 2009) .
Despite the prominent role of eCB signaling in the regulation of fear, anxiety, and stress responses (Hill et al., 2010; Lutz, 2007; Ramikie and Patel, 2012; Riebe et al., 2012) , the role of eCB signaling in the modulation of CeA circuitry has been relatively under-investigated due to anatomical studies that demonstrated very weak CB 1 receptor immunoreactivity within the CeA (Kamprath et al., 2011; Katona et al., 2001) . Here, we utilized new reagents to reveal abundant expression of eCB signaling elements at CeAL glutamatergic synapses and elucidate several mechanistically and temporally distinct modes of postsynaptic eCB mobilization in CeAL neurons subserving synaptic depression of CeAL glutamatergic neurotransmission.
RESULTS

Localization of Endocannabinoid Signaling Machinery in the CeAL
Although prior studies suggested a negligible role for eCBs in the modulation of CeA synaptic signaling (Katona et al., 2001 ), our in situ hybridization studies revealed a detectable CB 1 in situ signal within the CeA and strong expression in the basolateral amygdala (BLA) of wild-type (WT), but not CB 1 knockout (KO; Crn1 À/À ), mice ( Figures 1A-1C ). The presence of CB 1 mRNA in the majority of BLA neurons, which project glutamatergic afferents to the CeAL, suggested that BLA-CeA glutamatergic terminals might express CB 1 receptor protein ( Figure 1C ). Therefore, we employed a new high-affinity anti-CB 1 antibody to probe the localization of CB 1 receptors in the CeA (Yoshida et al., 2011) . Using this antibody, CB 1 receptors were clearly detected at high levels in both the CeAL and CeAM of WT, but not Crn1 À/À mice ( Figures 1D-1F ). Additionally, electron microscopic (EM) examination revealed CB 1 receptor expression in presynaptic boutons forming asymmetric synapses onto dendritic shafts and spines within the CeAL (Figures 1G1 , 1G2, and 1I). Considering that 2-AG is the primary ligand mediating eCB retrograde signaling at central synapses, we next examined the expression of the 2-AG synthesizing enzyme, DAGLa, in the CeA. In situ hybridization confirmed the expression of DAGLa in both the BLA and CeA (Figures 2A-2C ). Immunohistochemistry, using an anti-DAGLa antibody whose specificity in the forebrain has been confirmed in Dagla À/À mice (Ludá nyi et al., 2011), uncovered a punctate staining pattern throughout the CeAL (Figures 2D and 2E) . Double immunofluorescence labeling and confocal microscopy revealed DAGLa-positive puncta in close apposition to MAP2-labeled dendritic shafts in the CeAL ( Figures  2F-2H ), suggestive of DAGLa localization in presynaptic or postsynaptic compartments. To differentiate between these two possibilities, we performed immunoperoxidase labeling and utilized EM to visualize DAGLa at the synaptic level. We found that DAGLa was indeed localized postsynaptically in dendritic shafts and spine heads forming asymmetric synapses in the CeAL . Taken together, these data demonstrate the presence of eCB signaling elements at glutamatergic synapses in the CeAL. Figure 3D -3F), by Mann-Whitney U test. Although the selective effect of CP55940 on frequency, but not amplitude, of sEPSCs suggests a presynaptic locus of action, the lack of effect on PPR was surprising. Therefore, we evaluated the effects of 2-AG-ether, a metabolically stable analog of 2-AG, to better elucidate the mechanisms by which eCB signaling (Hanus et al., 2001) , rather than a synthetic CB 1 agonist, modulates glutamate release. Indeed, 50 mM 2-AGether caused robust synaptic depression (baseline 100.3% ± 1.2% vs. 2-AG-ether 49.1% ± 9.5%; t(3)=6.13, p<0.01 by paired t test) ( Figure 3G ) that was associated with a significant increase in PPR (t(3)=3.9, p<0.05 by paired t test) ( Figure 3G , inset). These data indicate that CB 1 receptors function to suppress glutamate release onto CeAL neurons.
Since CB 1 receptors in other brain regions robustly modulate GABAergic transmission (Castillo et al., 2012; Kano et al., 2009), we also tested the effects of CP55940 (5 mM) on GABAergic currents in the CeAL recorded in the presence of CNQX (20 mM) and AP-5 (50 mM). Generally consistent with our previous report (Katona et al., 2001) , and our EM observation of only a few CeAL GABAergic terminals being CB 1 -positive (Figures 1G1 , 1G2, and 1H), the effect on GABAergic currents was smaller and highly variable (baseline 100.0% ± 0.0% vs. (legend continued on next page)
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Endocannabinoid Signaling in the Central Amygdala 76.1% ± 9.3%; t(7)=2.6, p<0.05) ( Figure 3H ). When compared to the effect of CP55940 (5 mM) on glutamatergic transmission (from CeAL cells depicted in Figure 3B ), CP55940-induced depression of GABAergic currents showed a significantly greater variance compared to its effects on glutamate release (F test to compare variances, p<0.05) ( Figure 3I ). These data suggest that the major role of CB 1 signaling in the CeAL is to broadly regulate glutamatergic transmission, while synapse-or cell-type-specific modulation of GABAergic transmission may also occur.
Ca 2+ -Driven eCB Release in the CeAL We next examined whether CeAL glutamatergic synapses express depolarization-induced suppression of excitation (DSE), a Ca 2+ -DAGLa-dependent form of 2-AG-mediated eCB retrograde signaling (Ohno-Shosaku et al., 2012) . Two-way ANOVA revealed a significant effect of DSE induction (depolarization) and postsynaptic depolarization duration ( Figures 3J-3L ). Post hoc Sidak's analysis revealed depolarization of CeAL neurons from À70 to 0 mV resulted in a transient depression of eEPSC amplitude that was significantly different from corresponding baseline values after 5 s (p<0.0001) and 10 s (p<0.0001) of postsynaptic depolarization. One-way ANOVA followed by Dunnett's post hoc analysis revealed that CeAL 10 s DSE was blocked by the CB 1 receptor antagonist SR141716 (control 77.65% ± 2.06% vs. 5 mM SR141716 95.84% ± 4.84%, p<0.001) (Figures 3M-3O) and absent in Crn1 À/À mice (Crn1
102.5% ± 3.84%, p<0.0001) ( Figure 3O ). DSE was also blocked by the DAGL inhibitor THL (10 mM THL 91.20% ± 2.13%, p<0.05) ( Figure 3O ) and postsynaptic calcium chelation with 40 mM BAPTA (BAPTA 92.07% ± 1.46%, p<0.05) ( Figure 3O ), indicating that Ca 2+ -driven short-term eCB mobilization at CeAL glutamatergic synapses is mediated by 2-AG activation of CB 1 receptors. Intracellular loading of BAPTA alone did not affect frequency or amplitude of sEPSCs in CeAL neurons (control frequency 4.35 ± 0.9 Hz vs. BAPTA 4.1 ± 1.0 Hz, p>0.05; control amplitude 21.0 ± 1.0 pA vs. BAPTA 25.1 ± 2.6, p>0.05) ( Figure S1 available online).
Ca
2+ -Assisted mAChR-Driven eCB Release in the CeAL
In addition to Ca 2+ -dependent eCB release, Gq-receptor-driven eCB mobilization is a common feature of central synapses . For example, in the hippocampus, activation of Gq-coupled M 1 /M 3 muscarinic acetylcholine receptors (mAChRs) has been shown to mobilize eCB signaling in a calcium-independent manner (Kim et al., 2002; Straiker and Mackie, 2007) . Importantly, mAChRs are also highly expressed in the CeAL . To determine whether activation of mAChRs drives eCB mobilization in the CeAL, we first sought to examine the functional effects of mAChR activation on CeAL glutamatergic transmission. Experimental results from CeAL field potential recordings demonstrated that bath application of the mAChR agonist, Oxo-M (1 mM), reduced the amplitude of field excitatory postsynaptic potentials (fEPSPs) to 44.40% ± 3.69% of baseline (baseline 100.90% ± 1.18% vs. maximal Oxo-M-induced depression 44.40% ± 3.69%, p<0.0001 by paired t test) ( Figure 4A ), an effect that reversed following drug washout (baseline 100.90% ± 1.18% vs. post-Oxo-M washout 96.14% ± 7.13%, p=0.79 by paired t test) ( Figure 4A ). To test whether this Oxo-M-induced depression was mediated by mAChR activation, we bath applied 1 mM atropine, a nonselective mAChR antagonist, prior to and during Oxo-M (1 mM) application. Atropine application completely blocked the effect of 1 mM Oxo-M on fEPSPs (baseline 100.3% ± 0.79% vs. atropine+Oxo-M 96.47% ± 4.38%, p=0.87 by paired t test) ( Figure 4A ). Using whole-cell recordings, we found that Oxo-M caused robust depression of eEPSC amplitude, an effect reduced by the M 1 -preferring antagonist pirenzepine (1 mM; p<0.0001) and eliminated by the M 3 -preferring antagonist 4-DAMP (500 nM, p<0.0001) ( Figure 4B ). Oxo-Minduced synaptic depression was associated with a large increase in PPR, which was attenuated by pirenzepine (p<0.001) and blocked by 4-DAMP (p<0.0001) ( Figure 4C ), suggesting Oxo-M-induced synaptic depression is mediated by M 1/3 receptor activation and expressed presynaptically. Importantly, neither pirenzepine nor 4-DAMP exerted any effects on glutamatergic transmission when applied alone to control CeAL slices ( Figure S2 ). Additionally, our immunofluorescence confocal microscopy data revealed a moderate expression of the M 1 receptor subtype throughout the CeAL (Figures 4E 1 and 4E 2 ). At high magnification, M 1 staining appears as tiny puncta closely apposed to, but not overlapping with, MAP2-positve dendrites and perikarya. Together, these data demonstrate the presence of functional M 1/3 mAChRs in the CeAL.
Given the functional presence of M 1/3 mAChRs at CeAL glutamatergic synapses, we next evaluated the presence of mAChR-driven eCB release at excitatory synapses within the CeAL. It has been previously reported that DSE is effectively enhanced by the coincidental activation of Gq-coupled receptors, such as M 1 /M 3 receptors, via a mechanism involving Ca 2+ enhancement of PLCb activity Narushima et al., 2006 control and Oxo-M conditions were both associated with increases in PPR (p<0.05 and p<0.01, respectively, by paired t test; Oxo-M DSE PPR is significantly greater than control DSE PPR, p<0.05) ( Figure 4G ). We next investigated the mechanisms of Oxo-M-mediated enhancement of DSE in the CeAL. One-way ANOVA revealed that 1 mM Oxo-M-mediated DSE enhancement was attenuated in both Crn1 À/À CeAL cells (Oxo-M-WT 57.16% ± 2.56% vs.
Oxo-M-Crn1 À/À 87.03% ± 3.77%, p<0.0001) (Figures 4I and 4L) and CeAL cells pretreated with 10 mM THL for at least 60 min (Oxo-M 57.16% ± 2.56% vs. THL+ Oxo-M 86.08% ± 2.73%, p<0.0001) ( Figures 4I and 4L ). These results suggest that the simultaneous activation of mAChRs and postsynaptic depolarization results in the facilitation of 2-AG release at excitatory synapses within the CeAL. We next examined the muscarinic subtypes involved in the Oxo-M-mediated enhancement of depolarization-induced 2-AG release. Application of the M 1 -or the M 3 -preferring antagonists, 1 mM pirenzepine or 500 nM 4-DAMP, respectively, significantly reduced the 1 mM Oxo-M-dependent DSE enhancement (Oxo-M 57.16% ± 2.56% vs. Oxo-M+pirenzepine 73.92% ± 3.92%, p<0.01; Oxo-M 57.16% ± 2.56% vs. Oxo-M+4-DAMP 75.32% ± 4.75%, p<0.01) ( Figures 4J-4L ). Collectively, these results suggest that both M 1 and M 3 receptors play a role in the mAChR-mediated enhancement of CeAL DSE. Interestingly, in Crn1 À/À mice 10 s depolarization in the presence of Oxo-M elicited a small residual DSE (baseline 100.0% ± 0.0% vs. 87.03% ± 3.77%, p<0.01 by paired t test), suggesting possible CB 1 -independent residual effects induced by depolarization in the presence of Oxo-M.
Acute mAChR-Driven eCB Signaling in the CeAL
To determine whether acute application of Oxo-M can induce eCB release at CeAL glutamatergic synapses in the absence of depolarization, we applied Oxo-M for $20 min and assessed eCB release during this period using pharmacological and genetic approaches (see Figure 5A for experimental design Figures 5C, 5D , and 5K). We also examined the effects of SR141716 on Oxo-Minduced elevation in PPR and found that SR141716 pretreatment significantly attenuated the 1 mM Oxo-M-induced increase in PPR (p<0.0001) ( Figure 5E ). Importantly, the residual Oxo-M depression in SR141716-treated slices was associated with a residual, significant increase in PPR (p<0.001) ( Figure 5E ), indicating that the non-CB 1 component of Oxo-M-induced depression is also presynaptic in nature. Given that Oxo-M-induced synaptic depression is only partially CB 1 dependent, we sought to confirm these findings using Crn1 À/À mice. Figure 5F ). The maximal 1 mM Oxo-M-mediated increase in PPR was also significantly attenuated in Crn1 À/À mice (p<0.001) ( Figure 5G ). Collectively, these data indicate that Gq-receptor-driven eCB mobilization can be initiated by mAChR activity in the CeAL, which, in turn, contributes to Oxo-M-mediated synaptic depression of CeAL glutamatergic transmission.
Acute mAChR Activation Drives Ca 2+ -and DAGL-
Independent eCB Release
In light of previous studies, the roles of intracellular Ca 2+ and DAGL in Gq-receptor-driven eCB release remain uncertain (Edwards et al., 2006; Hashimotodani et al., 2005; Kim et al., 2002; Tanimura et al., 2010; Zhang et al., 2011 Figures 5I and 5K) . Lastly, since a recent study suggested phospholipase A2 (PLA2) may be required for 2-AG synaptic signaling in the cerebellum (Wang et al., 2012) , we tested the involvement of PLA2 in Oxo-M-mediated synaptic depression as an alternate mechanism by which mAChR activation could release 2-AG. However, the PLA2 inhibitor AACOCF3 (10 mM) did not significantly affect Oxo-M-mediated synaptic depression (p>0.05) ( Figures 5J and 5K ). These data suggest that acute mAChR-driven eCB release within the CeAL occurs independently of increases in [Ca 2+ ] i and does not require DAGL or PLA2 activity.
Prolonged mAChR Activation Drives Ca 2+ -and DAGLDependent eCB Release
The lack of calcium and THL sensitivity of acute Oxo-M-mediated synaptic depression was somewhat surprising in light of recent studies implicating Ca 2+ and DAGLa in Gq-receptordriven eCB release (Castillo et al., 2012; Hashimotodani et al., 2013; Katona and Freund, 2012) . To exclude the possibility that the non-CB 1 -dependent component of Oxo-M-induced acute depression was potentially confounding our analysis, we took an alternate approach aimed at selectively evaluating CB 1 -dependent synaptic effects of Oxo-M. To do this, we pretreated slices with 1 mM Oxo-M for R60 min and subsequently performed whole-cell patch clamp experiments where, after obtaining a stable baseline, we bath applied 5 mM SR141716 in the continued presence of 1 mM Oxo-M (see Figure 6A for experimental design). We reasoned that if prolonged mAChR activation induces tonic eCB release and activation of CB 1 receptors that subsequently depresses glutamatergic transmission, bath application of a CB 1 receptor antagonist should progressively relieve this tonic eCB inhibition and cause an apparent synaptic
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Endocannabinoid Signaling in the Central Amygdala potentiation. Thus, this experimental design would allow us to isolate eCB-CB 1 -mediated synaptic effects induced by prolonged mAChR activation. Consistent with this hypothesis, SR141716 (5 mM) wash-on significantly increased eEPSC amplitude in slices pretreated with 1 mM Oxo-M relative to control (no Oxo-M) conditions ( Figures 6B-6D ). Maximal potentiation induced by SR141716 in the presence of continuous Oxo-M was 143.20% ± 6.59% compared to 113.30% ± 4.09% under control conditions (p<0.001) ( Figures 6B-6D ). Interestingly, unlike eCB release following brief Oxo-M application, continuous mAChR activation appeared to promote eCB mobilization through a THL-and a Ca 2+ -dependent mechanism, as pretreatment with 10 mM THL or 20 mM intracellular BAPTA completely abolished SR141716-induced synaptic potentiation (p<0.0001 for each condition) (Figures 6C-6E ). Maximal SR141716-induced enhancement after 10 mM THL pretreatment (vehicle 113.30% ± 4.09% vs. THL + Oxo-M 107.60% ± 7.54%, p=0.88) ( Figures 6C  and 6D ) or 20 mM BAPTA postsynaptic loading (vehicle 113.30% ± 4.09% vs. BAPTA+ Oxo-M 99.25% ± 6.10%, p=0.34) ( Figures 6C and 6D) was not significantly different from SR141716-induced synaptic potentiation under control (no Oxo-M) conditions. These data suggest a possible temporal switch from a BAPTA-and THL-insensitive to a BAPTA-and THL-sensitive mAChR-driven eCB release mechanism following prolonged mAChR stimulation.
Acute mAChR Activation Drives Synaptic AEA Release Several recent studies have indicated that Gq-coupled receptors can mobilize AEA signaling (Chá vez et al., 2010; Grueter et al., 2010) . As such, we sought to investigate whether the Ca 2+ -and DAGL-independent acute Oxo-M-mediated synaptic depression might be mediated via AEA, rather than 2-AG, signaling. To examine this possibility, we determined the effects of inhibiting AEA degradation with the fatty acid amide hydrolase
Endocannabinoid Signaling in the Central Amygdala (FAAH) inhibitor, PF-3845, on Oxo-M-mediated acute synaptic depression (see Figure 7A for experimental design). PF-3845 (5 mM) pretreatment attenuated Oxo-M-mediated synaptic depression at both 0.3 mM (p<0.01) and 1 mM Oxo-M concentrations (p<0.01) (Figures 7B-7D ). We also tested the effects of the monoacylglycerol lipase (MAGL) inhibitor, JZL-184 (2 mM), on Oxo-M-induced synaptic depression to further rule out a role for 2-AG in acute Oxo-M-mediated synaptic depression. Consistent with the lack of BAPTA and THL sensitivity, prolonged MAGL blockade did not significantly affect subsequent Oxo-M-mediated acute synaptic depression at either 0.3 or 1 mM Oxo-M concentration (p>0.05 for each) (Figures 7B-7D ). Together, these data indicate that inhibiting AEA, but not 2-AG, degradation modifies acute Oxo-M-mediated synaptic depression; however, the direction of effect was somewhat unexpected. Specifically, if acute Oxo-M application causes release of AEA, blocking AEA degradation would be expected to increase Oxo-M synaptic depression rather than decrease it. The lack of enhancement was not due to a floor effect, since both maximal and submaximal concentrations of Oxo-M showed reduced efficacy in the presence of FAAH, but not MAGL, inhibition.
An alternate explanation for our results is that PF-3845, but not JZL-184, occludes the effects of Oxo-M. If this were the case, PF-3845 would be expected to cause synaptic depression alone, which would then occlude subsequent AEA-mediated synaptic depression initiated by acute Oxo-M application. Consistent with this hypothesis, 5 mM PF-3845 wash-on produced a CB 1 -dependent synaptic depression of glutamatergic transmission (PF-3845+vehicle 83.31% ± 5.34% vs. PF-3845+SR141716 102.80% ± 3.91%; t(14)=2.79, p<0.05) ( Figures  7E and 7F ). These data, combined with the lack of occlusion of acute Oxo-M-mediated synaptic depression by the MAGL inhibitor JZL-184, strongly implicate AEA, rather than 2-AG, as the eCB ligand subserving synaptic depression induced by acute Oxo-M application. However, it is possible the lack of occlusion by MAGL inhibition could be due to the fact that JZL-184 alone did not produce synaptic depression. To exclude this possibility and strengthen the support for an AEA-mediated process, we tested the ability of JZL-184 to cause synaptic depression of glutamatergic transmission. Consistent with our hypothesis, JZL-184 produced a CB 1 -dependent synaptic depression of glutamatergic signaling (JZL-184+vehicle 74.29% ± 4.24% vs. JZL-184+SR141716 96.38% ± 2.97%; t(9)=4.1, p< 0.01) (Figures 7G and 7H) . Taken together, these data provide converging evidence that acute Oxo-M-mediated synaptic depression causes synthesis/release of AEA that acts on CB 1 receptors to reduce glutamate release and that prolonged Oxo-M stimulation of mAChRs enhances DSE and causes tonic CB 1 -mediated synaptic depression via release of 2-AG through the canonical calcium-DAGL-dependent pathway ( Figures 7I and 7J) .
Lack of Oxo-M-Mediated Acute or Tonic eCB Signaling in Striatum Thus far, our data indicate that acute Oxo-M activation of mAChRs drives AEA release and subsequent depression of glutamatergic signaling via CB 1 activation. In contrast, prolonged mAChR activity results in 2-AG-mediated tonic CB 1 activation and enhancement of DSE. Since our data suggest temporally dissociated AEA and 2-AG release by the same stimulus, we wanted to examine whether this was a generalizable phenomenon. Therefore, we tested this phenomenon in the striatum given the strong morphological, hodological, and cytoarchitectural similarities between the striatum and the CeAL (McDonald, 1982) . Acute application of Oxo-M (1 mM) caused robust presynaptic depression in the striatum; however, this depression was not affected by SR141716 pretreatment (p>0.05) (Figures S3A-S3C) . Similarly, SR141716 failed to produce synaptic potentiation in the presence or absence of prolonged Oxo-M (1 mM) pretreatment ( Figure S3D ). In contrast, prolonged Oxo-M (1 mM) application was able to enhance DSE relative to control conditions (p<0.01) ( Figure S3E ), and this enhancement was blocked by SR141716 (p<0.0001). These data indicate that Oxo-M (1 mM) is able to enhance DSE in the striatum but that mAChRs do not trigger acute AEA or tonic 2-AG release to regulate glutamatergic transmission in this region. Thus, mAChRdriven multimodal eCB release may not be a generalized feature of central synapses.
DISCUSSION eCB Signaling at CeAL Glutamatergic Synapses
Here we report the distribution and subcellular localization of CB 1 receptors and the 2-AG synthetic enzyme, DAGLa, in the CeAL. In contrast to earlier studies, where CB 1 receptor expression was below detection threshold in the CeAL (Katona et al., 2001 ), here we utilized a high-affinity CB 1 receptor antibody to conclusively demonstrate the presence of CB 1 receptor protein in the CeAL (see Katona et al., 2006; Uchigashima et al., 2007) . High-resolution analyses showed CB 1 receptors localized to presynaptic terminals forming asymmetric synapses onto postsynaptic dendrites and dendritic spines. DAGLa was observed in the CeAL at both the mRNA and protein level, with ultrastructural studies demonstrating clear localization within postsynaptic dendritic spine heads and dendritic shafts adjacent to (I) Diagrammatic representation of differences between acute versus prolonged mAChR activation with Oxo-M. Acute Oxo-M application induces a short-lived ''burst'' of AEA to reduce afferent glutamate release, while prolonged mAChR activation causes a tonic calcium-and DAGL-dependent 2-AG release. (J) During prolonged mAChR activation, tonic 2-AG release continues and calcium-assisted mAChR-driven 2-AG release is induced by coincident postsynaptic depolarization (i.e., DSE enhancement in the presence of continuous Oxo-M). Ca+R-eCBR signifies calcium-assisted receptor driven eCB release; *p<0.05 and **p<0.01. Scale bars are as follows: 10ms, 100pA. Data presented as mean ±SEM. Also see Figure S3 . asymmetric synapses. Overall, these data support the well-established anatomical substrate for retrograde eCB signaling at central synapses . Consistent with our anatomical data, we found that activation of CB 1 receptors reliably reduced eEPSC amplitude, while effects on GABAergic transmission were more variable (Katona et al., 2001) . Interestingly, the cannabinoid agonist, CP55940, reduced eEPSC amplitude without a clear effect on PPR. In contrast, 2-AG-ether and DSE both cause synaptic depression associated with an increase in PPR. Although our data that CP55940 affected the frequency, but not amplitude, of sEPSCs suggest a presynaptic site of action, the lack of effect on PPR was unexpected and inconsistent with the effects of DSE and 2-AG-ether. Although previous studies have shown presynaptic inhibition of glutamate release in the CeAL by a decrease in the number of release sites rather than release probability (Delaney et al., 2007) , the mechanistic discrepancy between different CB 1 ligands is more difficult to explain. One possibility could be related to ligand-directed signaling at the CB 1 receptor (Hudson et al., 2010) , which would imply multiple presynaptic mechanisms downstream of CB 1 receptor activation could result in reduced glutamatergic transmission.
Multiple Modes of Postsynaptic eCB Mobilization by CeAL Neurons
Consistent with our studies demonstrating eCB signaling elements at CeAL excitatory synapses and CB 1 receptor-mediated depression of glutamatergic signaling, we found that CeAL neurons express prototypic 2-AG-mediated eCB signaling (i.e., DSE) mediated via a calcium-dependent, THL-sensitive, and CB 1 -dependent mechanism. These studies add to a recent demonstration of DSE in the CeAM (Kamprath et al., 2011) and tonic eCB release at CeAM GABAergic synapses (Roberto et al., 2010) . We next examined the mechanisms by which Gq-coupled mAChRs initiate eCB signaling at CeAL glutamatergic synapses. Our data indicate that acute application of Oxo-M causes a robust presynaptic depression that is partially mediated via activation of CB 1 receptors, consistent with findings in the periaqueductal grey (Lau and Vaughan, 2008) . Mechanistically, this acute CB 1 -dependent depression does not require elevations in intracellular calcium, is THL-insensitive, and does not require PLA2 activity. Moreover, inhibition of 2-AG degradation with JZL-184 did not affect Oxo-M-mediated acute synaptic depression. Taken together, these data appear to exclude 2-AG as the eCB ligand mediating the acute CB 1 -dependent synaptic depression induced by short-term mAChR activation.
We next tested the hypothesis that another eCB ligand, namely AEA, mediates eCB synaptic depression induced by acute mAChR activation. We found that FAAH inhibition, which on its own caused a CB 1 -dependent synaptic depression of glutamatergic transmission, partially occluded acute Oxo-M-mediated synaptic depression, implicating AEA in this process. Huang and Woolley (2012) , who showed that estrogen-induced depression of GABAergic transmission in the hippocampus was occluded by FAAH inhibition, but not MAGL inhibition, reached similar conclusions in their system (Huang and Woolley, 2012) . However, clear delineation of the biosynthetic pathway for synaptic AEA synthesis and the development of pharmacological tools to probe this system will be required to conclusively assign AEA as the eCB ligand mediating acute Oxo-M-driven synaptic depression.
In contrast to the putative AEA-mediated synaptic depression induced by acute mAChR activation, prolonged activation of mAChRs increases 2-AG-mediated signaling processes. First, after prolonged Oxo-M incubation, DSE is enhanced in an M 1 / 3 -dependent, THL-sensitive, and CB 1 -dependent manner, which is consistent with findings in other brain regions (Kano et al., 2009) . Interestingly, our SR141716 wash-on studies revealed strong synaptic potentiation by CB 1 receptor blockade in slices incubated with Oxo-M, but not vehicle. These data suggest tonic eCB release can be induced by prolonged mAChR activity. This synaptic potentiation required intracellular calcium and was THL-sensitive, strongly suggesting that this Oxo-Minduced tonic eCB signal is mediated by 2-AG synthesized by the canonical calcium-DAGL-dependent pathway (Kano et al., 2009) . These findings are consistent with recent studies in MAGL knockout mice, which suggest that 2-AG can act as a tonic eCB retrograde messenger (Pan et al., 2011) . Overall, these data indicate that CeAL neurons can mobilize multiple forms of eCB signaling to modulate afferent glutamatergic transmission.
Functional Implications of Temporally Dissociated Multimodal eCB Signaling
Previous studies have demonstrated that some cells can produce both AEA and 2-AG that act as retrograde eCBs signals (Huang and Woolley, 2012; Kim and Alger, 2010; Lerner and Kreitzer, 2012; Mathur et al., 2013; Puente et al., 2011) . Similarly, several studies have demonstrated that activation of Gqcoupled receptors can induce 2-AG and also AEA release in several brain regions (Chá vez et al., 2010; Grueter et al., 2010; Hashimotodani et al., 2013; Lerner and Kreitzer, 2012; Maccarrone et al., 2008) . However, our data provide experimental evidence that AEA and 2-AG can be differentially released in response to activation of the same Gq-coupled receptor, depending on the duration of Gq-receptor stimulation. Specifically, acute mAChR activation causes short-lived AEA-mediated synaptic depression, while prolonged mAChR stimulation causes 2-AG-mediated tonic eCB depression of glutamatergic transmission. Thus, in CeAL neurons, mAChR stimulation can initiate multimodal eCB signaling depending on the duration of Gq-receptor stimulation. The mechanistic basis for this temporal ''switch'' remains to be determined, but it is likely related to temporal differences in the coupling of mAChRs to distinct signaling pathways important for AEA and 2-AG synthesis (Mangoura et al., 1995; McKenzie et al., 1992; Schmidt et al., 1995) .
Recent studies have begun to highlight the dissociable roles of AEA and 2-AG signaling on multiple levels. For example, in the bed nucleus of the stria terminalis, AEA mediates long-term synaptic depression, while 2-AG mediates short-term synaptic depression in the form of DSE (Puente et al., 2011) . In contrast, in the striatum, different forms of associative neural activity can elicit both AEA-and 2-AG-mediated long-term depression (Lerner and Kreitzer, 2012) . More recently, different inhibitory synapses in the striatum have been shown to release AEA and 2-AG in a state-dependent manner (Mathur et al., 2013) . Thus, AEA and 2-AG are clearly not ''redundant'' signaling molecules but have distinct duration-, activity-, and synapse-dependent effects. Here, we add to this eCB signaling diversity by demonstrating temporally dissociated mobilization of AEA and 2-AG signaling in response to mAChR activity. Continued investigation of multimodal eCB signaling could provide insight into the activity-dependent mechanisms sculpting synaptic efficacy.
Here we show that eCB signaling suppresses afferent glutamatergic transmission onto CeAL neurons, which could represent an important synaptic mechanism regulating stress response physiology and anxiety-like behaviors. Specifically, inhibition of excitatory drive to protein kinase C-d-expressing GABAergic CeAL projection neurons would disinhibit CeAM neurons and increase fear and anxiety responses (Haubensak et al., 2010) . This model is consistent with well-known anxiogenic effects of high doses of exogenous cannabinoids (Patel and Hillard, 2006) and therefore could represent a synaptic correlate of cannabinoid anxiogenesis. In contrast, inhibition of glutamatergic drive to somatostatin-expressing GABAergic neurons could disinhibit CeAL projection neurons and, in turn, inhibit CeAM activity, thereby reducing anxiety and fear responses, which is the primary physiological function of eCB signaling (Hill et al., 2009; Lutz, 2007; Riebe et al., 2012) . Future studies aimed at elucidating the afferent-and cell type-specific effects of eCB signaling within the CeA microcircuitry will be critical to advancing our understanding of the synaptic mechanisms by which eCB signaling modulates stress-responses, anxiety, and emotional learning. 
Anatomical Experiments
In situ hybridization, immunoperoxidase, and immunoelectron microscopy experiments were conducted as previously described (Pé terfi et al., 2012) and detailed in the Supplemental Information. Briefly, we prepared antisense and sense riboprobes against a 1,170-bp-long section (from position 1,967 to 3,136 in the open reading frame) of mouse DAGLa coding sequence using the following primers: forward, 5 0 -TCA TGG AGG GGC TCA ATA AG, and reverse, 5 0 -CTA GCG TGC CGA GAT GAC CA (Katona et al., 2006) . The CB 1 riboprobe was generated against a 738-bp-long region of mouse CB 1 coding sequence (from position 548 to 1,285 in the open reading frame; forward primer, 5 0 -CTA ATC AAA GAC TGA GGT TA, and reverse primer, 5 0 -CAC AGA GCC TCG GCA GAC GT). Free-floating immunoperoxidase staining also followed the previously established protocol (Pé terfi et al., 2012) . For EM analyses, after development of the immunostaining, the sections were treated with 0.5% OsO 4 , dehydrated in an ascending series of ethanol and acetonitrile solutions, and finally embedded into DurcupanÔ ACM Fluka (Sigma). During dehydration, sections were also treated with 1% uranyl acetate in 70% ethanol for 20 min. After overnight incubation in Durcupan, the sections were mounted onto glass slides and coverslips were sealed by polymerization of Durcupan at 56 C for 48 hr. From sections embedded in Durcupan, areas of interest from the CeAL were re-embedded and resectioned for electron microscopy.
Electrophysiology
Whole-cell voltage clamp and field potential electrophysiological experiments were carried out in 4-to 5-week-old male ICR mice as described previously Sumislawski et al., 2011) . Briefly, mice were anesthetized with isoflurane and transcardially perfused with ice-cold high-sucrose, low Na + -containing ACSF. Following decapitation, the brain was removed and a 3 mm coronal block of the amygdala was cut using an ice-chilled, coronal brain matrix. Thereafter, coronal slices (200-300 mm) were made using a Leica VT1000S vibratome (Leica Microsystems, Bannockburn, IL) in 1 C -4 C oxygenated (95% v/v O 2 , 5% v/v CO 2 ) ACSF comprised of (in mM) the following: 208 sucrose, 2. -gluconate, 4 NaCl, 10 HEPES, 4 Mg-ATP, 0.3 Na-GTP, and 10 Na-phosphocreatine (pH 7.25-7.35, adjusted with KOH). eEPSCs were recorded from CeAL neurons via local microstimulation $100mm from the cell soma. Experimental details are described in the Supplemental Information.
Statistical Analysis
Statistical significance between the means of two groups was assessed using two-tailed paired or unpaired t test unless variance differed significantly (Bartlett's test for equal variances), in which case nonparametric MannWhitney (U) test was used. Statistical comparisons between two or more groups were performed using one or two-way analysis of variance (ANOVA). 
